BIOS Capital Management, LP Q4 2024 Filing

Filed February 10, 2025

Portfolio Value

$95.9B

Holdings

6

Report Date

Q4 2024

Filing Type

13F-HR

All Holdings (6 positions)

#StockSharesValue% PortfolioType
1
ACTUACTUATE THERAPEUTICS INC
9,893,651$78.8B82.15%
2
CGTXCOGNITION THERAPEUTICS INC
6,000,000$4.2B4.39%
3
RNTXAILERON THERAPEUTICS INC
1,690,751$3.9B4.06%
4
LTRNLANTERN PHARMA INC
1,207,709$3.9B4.02%
5
IRDOPUS GENETICS INC
2,480,983$3.0B3.08%
6
INABEURIN8BIO INC
8,600,001$2.2B2.31%